Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Estimated Industry Valuation for the Lumbosacral Radicular Pain Management Sector?
The market size for managing lumbosacral radicular pain has seen substantial expansion in the recent past. Anticipated to surge from $0.85 billion in 2024 to $0.9 billion in 2025, it is expected to display a compound annual growth rate (CAGR) of 5.8%. Several factors are responsible for the growth observed in the historical period, including increased incidents of lumbar disc herniation, heightened awareness about spinal disorders, the escalating population of the elderly, advancements in diagnostic imaging methods, and the growing adoption of non-invasive pain management treatments.
The market size for managing lumbosacral radicular pain is anticipated to experience robust growth over the coming years, ballooning to $1.11 billion by 2029, with a CAGR of 5.5%. This expansion over the forecasted period can be credited to advancements in minimally invasive surgical procedures, growing use of biologic therapies, an increased emphasis on personalized pain management, the escalating demand for outpatient pain clinics, as well as the incorporation of digital health and telemedicine into pain management. Significant trends for the forecast period entail progress in minimally invasive spine surgeries, improvements in neurostimulation devices, the use of biologic therapies such as platelet-rich plasma, AI-guided diagnostics and personalized treatment strategies, coupled with the invention of cutting-edge non-opioid analgesics.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24592&type=smp
What Forces Are Driving The Growth Of The Lumbosacral Radicular Pain Management Market?
An increase in cases of back pain disorders is anticipated to boost the lumbosacral radicular pain management market. These disorders of back pain include different conditions that disrupt the functionality of the spine, muscles, or nerves in the back, leading to discomfort or pain. The escalation in these disorders is a result of sedentary lifestyles which leads to weakened back muscles, poor posture, and enduring pain. The goal of lumbosacral radicular pain management is to alleviate irritation of the nerve root in the lower back, thus reducing pain and inflammation, restoring mobility, and enhancing life quality. For example, in June 2024, data from the Australian Institute of Health and Welfare, a government agency in Australia, revealed that in 2022, over half (52%) of all hospital admissions for back issues were due to back or spine pain. In this category, lower back pain held the majority share at 27%, followed by neck pain at 6.2% and radiculopathy at 6.0%. Furthermore, back problems escalated in 2023 to become the third highest contributor to the total health burden, accounting for 4.3%. As a result, the escalating cases of back pain disorders act as a driving force for the growth of the lumbosacral radicular pain management market.
How Is The Lumbosacral Radicular Pain Management Industry Segmented Across Key Parameters?
The lumbosacral radicular pain management market covered in this report is segmented –
1) By Medication: Non-Steroidal Anti-Inflammatory Drugs, Opioids, Antidepressants, Anticonvulsants, Steroids
2) By Physical Therapy: Manual Therapy, Exercise Therapy, Electrotherapy, Thermal Therapy, Hydrotherapy
3) By Route Of Administration: Oral, Topical
4) By End-User: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
Subsegments:
1) By Non-Steroidal Anti-Inflammatory Drugs: Ibuprofen, Naproxen, Diclofenac, Celecoxib, Etoricoxib
2) By Opioids: Tramadol, Oxycodone, Morphine, Hydrocodone, Fentanyl
3) By Antidepressants: Amitriptyline, Nortriptyline, Duloxetine, Desvenlafaxine, Venlafaxine
4) By Anticonvulsants: Gabapentin, Pregabalin, Carbamazepine, Lamotrigine, Topiramate
5) By Steroids: Dexamethasone, Methylprednisolone, Prednisone, Triamcinolone, Hydrocortison
What Notable Trends Are Shaping The Direction Of The Lumbosacral Radicular Pain Management Market?
Leading businesses in the lumbosacral radicular pain management market are concentrating on the creation of cutting-edge treatments such as investigational oral NaV1.8 pain signal inhibitors, with the aim of providing long-lasting pain relief without the use of opioids. This experimental oral NaV1.8 inhibitor is a medication still in the trial phase, and its main function is to target the NaV1.8 sodium channel, which transmits pain through sensory nerves. For example, in December 2024, the American biotech firm Vertex Pharmaceuticals publicized the results from its Phase 2 trial of Suzetrigine for painful lumbosacral radiculopathy (LSR). The research met its primary aim, demonstrating a clinically relevant and statistically significant decrease in pain from the baseline in those who were given Suzetrigine. Furthermore, Suzetrigine was generally well-received and no severe side effects were noted. Vertex intends to evaluate the efficacy of the drug better in future Phase 3 studies by countering the high placebo response.
Which Companies Currently Dominate The Competitive Landscape In The Lumbosacral Radicular Pain Management Industry?
Major companies operating in the lumbosacral radicular pain management market are Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Sanofi SA, Bristol-Myers Squibb, AstraZeneca plc, Novartis AG, GSK plc, Medtronic plc, Eli Lilly and Company, Amgen Inc, Koninklijke Philips NV, Stryker Corporation, Teva Pharmaceutical Industries Ltd, Boston Scientific Corporation, Dr Reddy’s Laboratories Ltd, NuVasive Inc., Nobel Biocare Holdings AG, Ultradent Products Inc., Nevro Corp., Zynex Inc., Eliem Therapeutics, Vertebral Technologies Inc., Semnur Pharmaceuticals Inc.
Get The Full Report Here:
Which Geographic Regions Are Driving Demand In The Lumbosacral Radicular Pain Management Market?
North America was the largest region in the lumbosacral radicular pain management market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lumbosacral radicular pain management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=24592&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
